YAKIRA CAPITAL MANAGEMENT, INC. – Merrimack Pharmaceuticals, Inc. Transaction History
YAKIRA CAPITAL MANAGEMENT, INC. portfolio value:
$434,000
portfolio value
YAKIRA CAPITAL MANAGEMENT, INC. quarter portfolio value change:
-36.97%
quarter
Merrimack Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -255K | $3.75 | 115.82K | |
| Q2 2022 | share | Increase | +30.60% | 27.13K shares | 128K | $5.95 | 115.82K |
| Q1 2022 | share | Increase | +20.74% | 15.23K shares | 274K | $6.33 | 88.68K |
| Q4 2021 | share | Increase | +21.14% | 12.81K shares | -6K | $3.93 | 73.45K |
| Q3 2021 | share | 0.00% | 0 shares | -94K | $4.83 | 60.63K | |
| Q2 2021 | share | 0.00% | 0 shares | 6K | $6.39 | 60.63K | |
| Q1 2021 | share | 0.00% | 0 shares | -37K | $6.28 | 60.63K | |
| Q4 2020 | share | Decrease | -9.41% | -6.3K shares | 150K | $6.89 | 60.63K |
| Q3 2020 | share | 0.00% | 0 shares | 45K | $4 | 66.93K | |
| Q2 2020 | share | 0.00% | 0 shares | 79K | $3.33 | 66.93K | |
| Q1 2020 | share | 0.00% | 0 shares | -67K | $2.15 | 66.93K | |
| Q4 2019 | share | 0.00% | 0 shares | -90K | $3.15 | 66.93K | |
| Q3 2019 | share | Decrease | -21.32% | -18.14K shares | -104K | $3.98 | 66.93K |
| Q2 2019 | share | 0.00% | 0 shares | -60K | $3.32 | 85.07K | |
| Q1 2019 | share | 0.00% | 0 shares | 207K | $3.82 | 85.07K | |
| Q4 2018 | share | 0.00% | 0 shares | -99K | $2.12 | 85.07K | |
| Q3 2018 | share | 0.00% | 0 shares | 28K | $2.93 | 85.07K | |
| Q2 2018 | share | Decrease | -10.08% | -9.53K shares | -270K | $2.7 | 85.07K |
| Q1 2018 | share | Decrease | -11.36% | -12.11K shares | -262K | $4.42 | 94.60K |
| Q4 2017 | share | Increase | +444.99% | 87.14K shares | 637K | $5.63 | 106.72K |
| Q3 2017 | share | Increase | 0.00% | 19.58K shares | 224K | $7.98 | 19.58K |